MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer
出版年份 2014 全文链接
标题
MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer
作者
关键词
-
出版物
JOURNAL OF PATHOLOGY
Volume 235, Issue 1, Pages 25-36
出版商
Wiley
发表日期
2014-09-17
DOI
10.1002/path.4443
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation
- (2015) Zhenze Zhao et al. Oncotarget
- Hypoxia promotes vasculogenic mimicry formation by inducing epithelial–mesenchymal transition in ovarian carcinoma
- (2014) Jing Du et al. GYNECOLOGIC ONCOLOGY
- MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer
- (2014) Guoyan Liu et al. JOURNAL OF PATHOLOGY
- Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation
- (2014) M Yin et al. ONCOGENE
- miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer
- (2014) S-Y Wen et al. ONCOGENE
- MicroRNA-mRNA functional pairs for cisplatin resistance in ovarian cancer cells
- (2014) Mei Liu et al. Chinese Journal of Cancer
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrated Analyses Identify a Master MicroRNA Regulatory Network for the Mesenchymal Subtype in Serous Ovarian Cancer
- (2013) Da Yang et al. CANCER CELL
- New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
- (2013) S. Banerjee et al. CLINICAL CANCER RESEARCH
- Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition
- (2013) David Balli et al. EMBO JOURNAL
- miR-506 Regulates Epithelial Mesenchymal Transition in Breast Cancer Cell Lines
- (2013) Himanshu Arora et al. PLoS One
- PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation
- (2013) María Isabel Rodríguez et al. PLoS Genetics
- MicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)
- (2013) Xiang-Ming Ding Chinese Journal of Cancer
- High Expression of Nuclear Snail, but not Cytoplasmic Staining, Predicts Poor Survival in Nasopharyngeal Carcinoma
- (2012) Wei-Ren Luo et al. ANNALS OF SURGICAL ONCOLOGY
- MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer
- (2012) Chun-Wen Cheng et al. BREAST CANCER RESEARCH AND TREATMENT
- Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail
- (2012) L. Hao et al. BRITISH JOURNAL OF DERMATOLOGY
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
- (2012) Marilena V. Iorio et al. EMBO Molecular Medicine
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles
- (2012) Amanda Tivnan et al. PLoS One
- Good things come in small packages
- (2012) Juan R. Cubillos-Ruiz et al. OncoImmunology
- MicroRNA-138 suppresses epithelial–mesenchymal transition in squamous cell carcinoma cell lines
- (2011) Xiqiang Liu et al. BIOCHEMICAL JOURNAL
- Let-7 and miR-200 microRNAs: Guardians against pluripotency and cancer progression
- (2011) Marcus E. Peter CELL CYCLE
- Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer
- (2011) Hiroshi Kurahara et al. JOURNAL OF SURGICAL ONCOLOGY
- Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
- (2011) Karen A Gelmon et al. LANCET ONCOLOGY
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Twist2 contributes to breast cancer progression by promoting an epithelial–mesenchymal transition and cancer stem-like cell self-renewal
- (2011) X Fang et al. ONCOGENE
- EMT: When epithelial cells decide to become mesenchymal-like cells
- (2009) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- NF-κB and epithelial to mesenchymal transition of cancer
- (2008) Chengyin Min et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started